z-logo
open-access-imgOpen Access
High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection
Author(s) -
Michael Schintler,
Friederike Traunmüller,
Julia Metzler,
G. Kreuzwirt,
Stephan Spendel,
O. Mauric,
Martin Popovic,
E. Scharnagl,
Christian Joukhadar
Publication year - 2009
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkp230
Subject(s) - fosfomycin , daptomycin , medicine , staphylococcus aureus , diabetic foot , soft tissue , methicillin resistant staphylococcus aureus , bone infection , osteomyelitis , antimicrobial , vancomycin , surgery , microbiology and biotechnology , diabetes mellitus , bacteria , biology , endocrinology , genetics
Appropriate antimicrobial therapy and surgical intervention may be required in diabetic patients presenting with severe bacterial foot infection. Methicillin-resistant Staphylococcus aureus (MRSA) agents such as fosfomycin are increasingly in demand because of recent concern regarding vancomycin and daptomycin efficacy and constant use. Intravenous fosfomycin is approved for the therapy of severe soft tissue infections and is highly active against methicillin-susceptible S. aureus and MRSA. in the present study we investigated fosfomycin's ability to penetrate bone tissue in diabetic patients suffering from severe bacterial foot infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom